We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Wants Arrow and Watson to Divest Two Generics
FTC Wants Arrow and Watson to Divest Two Generics
December 4, 2009
The FTC has proposed a consent order to ensure competition for two generic drugs after Watson Pharmaceuticals’ acquisition of Arrow Pharmaceuticals.